Q1 FY 20 Performance Update

Our Focus continues to be on: 1 Delivering high growth in emerging markets 2 Enhancing customer service 3 Launching new products in US and other markets and continue to build a healthy pipeline Improving efficiency and cost controls, 4 elimination of waste 5 Divesting non strategic assets and brands 6 Improving internal processes 7 Engaging with USFDA to resolve outstanding concerns and focus on quality

View entire presentation